Advertisement
Advertisement

MXCT

MXCT logo

MaxCyte Inc

4.45
USD
+0.18
+4.21%
Dec 18, 13:49 UTC -5
Open

MaxCyte Inc Profile

About

MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.

Info & Links

CEO

Maher Masoud

Headquarters

9713 KEY WEST AVENUE, SUITE 400
ROCKVILLE, MD 20850, UNITED STATES

Auditor

CohnReznick LLP

Share holders

35

Employees

143

MaxCyte Inc Statistics

Valuation Measures

Market Capitalization2

469.39M

Enterprise Value

432.43M

Enterprise Value/EBITDA(ttm)

-8.81

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.92

Price to Book(mrq)

2.11

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

84.93%

Operating Margin(ttm)

-78.36%

Profit Margin(ttm)

-87.28%

Return on Equity(ttm)

-16.00%

Return on Invested Capital(ttm)

-16.14%

Return on Assets(ttm)

-13.93%

Income Statement

Revenue(ttm)

45.60M

Revenue Per Share(ttm)

0.43

Gross Profit(ttm)

39.21M

EBITDA(ttm)3

-49.08M

Net Income Available to Common(ttm)

-35.74M

Diluted EPS(ttm)

-0.34

Share Statistics

Beta (5Y Monthly)

1.37

52-Week Change

-11.35%

S&P 500 52-Week Change

27.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

105.48M

Dividend Yield

0.00%

Float4

102.52M

% Held by Insiders

3.00%

% Held by Institutions

68.81%

Balance Sheet

Total Cash(mrq)

153.83M

Total Cash Per Share(mrq)

1.46

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.81%

Quick Ratio(mrq)

9.22%

Book Value Per Share(mrq)

2.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.19

Free Cash Flow(ytd)

-21.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement